# Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI

> **NCT02936817** · PHASE4 · COMPLETED · sponsor: **FLUIDDA nv** · enrollment: 10 (estimated)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- COPD

## Interventions

- **DEVICE:** Aerobika® Device
- **RADIATION:** HRCT scans

## Key facts

- **NCT ID:** NCT02936817
- **Lead sponsor:** FLUIDDA nv
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02936817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02936817, "Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02936817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*